INTRODUCTION
Quiescent and actively dividing (activated) stem cells coexist in adult stem cell niches (Li and Clevers, 2010) . Stem cell quiescence and activation play an essential role in many organs, underlying tissue maintenance, regeneration, function, plasticity, aging, and disease. Quiescent stem cells dynamically integrate extrinsic and intrinsic signals to either actively maintain their dormant state or become activated to divide and give rise to differentiated progeny (Cheung and Rando, 2013) . To illuminate their biology and their molecular regulation, it is essential to be able to prospectively identify and purify quiescent stem cells. However, this has been exceedingly difficult in any organ, including the adult brain.
Adult neural stem cells (NSCs) continuously generate neurons throughout life in two brain regions: the subgranular zone (SGZ) of the hippocampus and the ventricular-subventricular zone (V-SVZ), adjacent to the lateral ventricles. The V-SVZ is the largest germinal region in the adult mammalian brain and generates olfactory bulb interneurons and oligodendrocytes. Within the V-SVZ, glial fibrillary acidic protein (GFAP)-positive type B cells with hallmark features of astrocytes are stem cells and have multipotent self-renewing capacity in vitro (Doetsch et al., 1999a; Laywell et al., 2000; Imura et al., 2003; Garcia et al., 2004; Sanai et al., 2004; Ahn and Joyner, 2005; Mirzadeh et al., 2008; Beckervordersandforth et al., 2010; Lee et al., 2012) . In vivo, actively dividing V-SVZ stem cells are eliminated by antimitotic treatment (Pastrana et al., 2009) . In contrast, slowly dividing astrocytes are label-retaining cells (LRCs), survive treatment with antimitotic drugs and regenerate the V-SVZ, and give rise to neurons under homeostasis (Doetsch et al., 1999a; Ahn and Joyner, 2005; Giachino and Taylor, 2009; Nam and Benezra, 2009; Kazanis et al., 2010; Basak et al., 2012) .
Recently, novel features of the anatomical organization of the V-SVZ stem cell niche have been uncovered. GFAP + type B1 cells have a radial morphology and span different compartments of the stem cell niche (Silva-Vargas et al., 2013) . Their apical processes contact the lateral ventricle at the center of pinwheel structures formed by ependymal cells, exhibit a primary cilium, and are exposed to signals in the cerebrospinal fluid (CSF) (Doetsch et al., 1999a , Mirzadeh et al., 2008 , Beckervordersandforth et al., 2010 , Kokovay et al., 2012 . Their basal processes contact blood vessels, which are an important proliferative niche in the adult V-SVZ (Shen et al., 2008; Mirzadeh et al., 2008; Tavazoie et al., 2008; Kazanis et al., 2010; Kokovay et al., 2010 , Lacar et al., 2011 .
Various molecular markers have been used for the in vivo identification of V-SVZ stem cells and their purification (reviewed in Pastrana et al., 2011) . Nestin and Sox2 are widely used as NSC markers in both the embryonic and adult brain (Lendahl et al., 1990; Graham et al., 2003; Kazanis et al., 2010; Imayoshi et al., 2011; Marqué s-Torrejó n et al., 2013) . CD133 (Prominin), a transmembrane glycoprotein expressed on primary cilia of neural progenitors (Uchida et al., 2000; Marzesco et al., 2005; Pinto et al., 2008; Cesetti et al., 2011) has been used to distinguish GFAP + CD133 + stem cells from niche astrocytes (Mirzadeh et al., 2008 , Beckervordersandforth et al., 2010 . Combinations of markers are beginning to be identified that allow the purification of different subpopulations of V-SVZ cells, in particular of activated stem cells, including epidermal growth factor receptor (EGFR) (Doetsch et al., 2002; Pastrana et al., 2009) , and brain lipid binding protein (BLBP) (Giachino et al., 2014) . To date, however, combinations of markers have not been identified that allow the prospective isolation of quiescent V-SVZ stem cells. This is crucial to illuminate the functional properties and gene regulatory networks of quiescent adult NSCs. Herein, we prospectively identify and isolate quiescent adult NSCs from their niche. Our findings reveal that CD133 + astrocytes comprise two functionally distinct populations, quiescent NSCs (qNSCs) and activated NSCs (aNSCs), which differ dramatically in their in vivo cell cycle status and lineage kinetics, their in vitro colony-forming efficiencies, and their molecular signatures. Notably, qNSCs only rarely form colonies in vitro and are natively Nestin negative but upregulate both Nestin and EGFR on activation. qNSCs also share common molecular features with their counterparts in other organs. Finally, we identify GPCR ligands that actively maintain the quiescent state of qNSCs.
RESULTS

Two Populations of CD133
+ V-SVZ Astrocytes Contact the Lateral Ventricle The intermediate filament GFAP is one of the few markers of type B1 astrocytes (Doetsch et al., 1997; Mirzadeh et al., 2008) . However, due to its filamentous nature, it is difficult to perform colocalization studies with GFAP, and it cannot be used for live cell sorting. GFAP::GFP mice, in which GFP is expressed under the control of the human GFAP promoter (Zhuo et al., 1997) , are a useful tool for visualizing V-SVZ astrocytes in vivo and for their purification by fluorescence-activated cell sorting (FACS) (Tavazoie et al., 2008; Platel et al., 2009 , Shen et al., 2008 , Pastrana et al., 2009 Beckervordersandforth et al., 2010) . Whole-mount preparations allow the pinwheel architecture of the walls of the lateral ventricle to be clearly visualized. We confirmed that, in GFAP::GFP mice, type B1 astrocytes contacting the ventricle at the center of pinwheels were GFP + and GFAP + , and frequently had a primary cilium, but lacked S100b expression, a marker of mature astrocytes that are found deeper in the tissue at the interface with the striatum (Figures S1A, S1C, and S1D available online).
Notably, a subset of cells localized within individual pinwheels was EGFR + (11.4% ± 1.3%; n = 129 pinwheels) ( Figures 1A and 1B). These ventricle-contacting EGFR + cells coexpressed both GFAP protein and GFP in GFAP::GFP mice ( Figure S1B ; Pastrana et al., 2009 ) and were observed throughout the rostrocaudal axis of the V-SVZ, with 45.7% ± 4.4% of pinwheels containing EGFR + cells.
To define markers for EGFR-negative type B1 cells contacting the ventricle, we examined the expression of CD133 (Prominin), which is expressed by ependymal cells and on the primary cilium of some type B1 cells (Coskun et al., 2008; Mirzadeh et al., 2008; Beckervordersandforth et al., 2010) . We immunostained whole mounts of GFAP::GFP mice for EGFR and CD133 in conjunction with b-catenin (to label pinwheels) or acetylated tubulin (to detect primary cilia (Figures 1C-1F ; Figures S2B and S2D) . Finally, we also observed GFAP::GFP + cells contacting the ventricle, which had a primary cilium that was CD133 negative (Figures S2A and S2C) .
Visualizing the in vivo morphology of CD133 + type B1 cells is not feasible by immunostaining. To this end, we cloned and electroporated a construct that expresses membrane-targeted mCherry under the control of the mouse minimal P2 (Prominin-1) Figure S3 .
promoter (mP2-mCherry; Figure S3A ) into the lateral ventricle and analyzed whole mounts 2 days later. Both multiciliated flat ependymal cells possessing typical cuboidal morphology and radial cells with B1 morphology were labeled by this construct (Figure 2A) , and all coexpressed CD133 protein (23/23 cells; Figures  S3B-S3D ). Radial mP2-mCherry + cells expressed CD133 either at the tip of their primary cilium ( Figure S3C ) or diffusely on their apical surface ( Figure S3D ) and were GFAP + (data not shown).
To define the cell cycle status and relationship of radial mP2-mCherry + cells with ependymal cells and blood vessels, electroporated whole mounts were immunostained for combinations of EGF-A647, MCM2, b-catenin, and Laminin to label activated stem cells, dividing cells, pinwheels, and blood vessels, respectively. All radial mP2-mCherry + cells, regardless of MCM2 expression or epidermal growth factor (EGF)-ligand binding, had a typical B1 morphology with an apical process contacting the ventricle at the center of pinwheels and a long basal process extending away from the surface, which frequently terminated on blood vessels ( Figure 3C ).
We assessed the purity of the sorted populations using qRT-PCR and acute immunostaining. qRT-PCR confirmed that sorted populations were appropriately enriched in Gfap, GFP, Prom1, and Egfr expression ( Figures S4Q-S4T ). Acute immunostaining showed that both GFAP::GFP + CD133 + and GFAP::GFP + CD133 + EGFR + populations were highly enriched in GLAST and GLT1 ( Figures S4J and S4K )-glutamate aspartate transporters expressed in astrocytes-as well as BLBP ( Figure S4M ), that they largely or completely lacked S100b ( Figure S4L ) and that they were almost completely negative for the neuroblast markers DCX and bIII tubulin ( Figures S4O and S4P Figure S6 ).
+ V-SVZ Cells Have Different Cell Cycle Properties Quiescent stem cells are largely dormant and lack markers of proliferation such as Ki67 and MCM2 that are expressed in actively dividing cells, but not during the quiescent G 0 state (Maslov et al., 2004) . Both markers are expressed during G 1 , with MCM2 being expressed earlier than Ki67. Cycling GFAP + V-SVZ cells in vivo have a fast cell cycle (Ponti et al., 2013) . To determine the cell cycle properties of CD133 + astrocyte subpopulations in vivo, we used multiple approaches. First, we determined the instantaneous cell cycle status of FACS-purified cells by acute immunostaining for proliferation-associated markers. GFAP::GFP + CD133 + EGFR + cells were highly enriched in both Ki67 and MCM2 (64% ± 5.2% and 87.3% ± 1.2%, LRCs are slowly cycling cells whose DNA remains labeled after prolonged administration of thymidine analogs and a long chase period (Wilson et al., 2008 Figure 3F ). Finally, we confirmed the different proliferation characteristics of both populations in vivo by infusing cytosine-b-D-arabinofuranoside (Ara-C) directly on the brain surface to eliminate dividing cells (Doetsch et al., 1999b) . GFAP::GFP + CD133 + cells survived 6 days of Ara-C treatment, whereas the more rapidly dividing GFAP::GFP + CD133
+ EGFR + cells were eliminated ( Figure 3G ).
Thus, although CD133 is regulated in a cell-cycle-dependent manner in dividing neural cell lines (Sun et al., 2009) , in the V-SVZ niche, CD133 is expressed in both dividing and nondividing cells in vivo. Together, these findings reveal that GFAP::GFP + CD133 + cells are largely quiescent in vivo, whereas GFAP::GFP + CD133 + EGFR + cells are actively dividing. Based on their cell cycle properties and the functional studies described below, hereafter we refer to these populations as qNSCs and aNSCs, respectively ( Figure 3H ).
qNSCs and aNSCs Are Both Neurogenic In Vivo but Differ in Their Kinetics
To assess the in vivo potential of quiescent and activated stem cells, we transplanted purified qNSCs (1 week, n = 8; 1 month, n = 5) and aNSCs (1 week, n = 5; 1 month, n = 11) isolated from GFAP::GFP;b-Actin-PLAP mice (Zhuo et al., 1997; DePrimo et al., 1996) into the SVZ of wild-type recipient mice ( Figure 4A ). The donor cells were histochemically visualized based on their expression of the reporter human placental alkaline phosphatase (PLAP). In mice transplanted with aNSCs, many migrating neuroblasts were present in the V-SVZ, the rostral migratory stream (RMS), and the olfactory bulb after only 1 week ( Figures  4E-4G ), confirming their activated state. However, in mice transplanted with qNSCs, no neuroblasts were observed at this time point, and PLAP + cells were only present in the V-SVZ ( Figures  4B-4D ). In contrast, after 1 month, both populations generated mature olfactory bulb interneurons ( Figures 4J and 4M) , and PLAP + cells were still present in the V-SVZ in all transplants (Figures 4H and 4K) . Interestingly, migrating neuroblasts were also present in the RMS in 3 out of 5 qNSC and 3 out of 11 aNSC transplanted brains, demonstrating that both populations continue to generate neurons after 1 month in vivo (Figures 4I and 4L) . Oligodendrocytes were also formed by both transplanted populations (data not shown). These data show that both qNSCs and aNSCs can give rise to neurons and retain long-term neurogenic potential in vivo but exhibit very different kinetics of cell generation.
qNSCs and aNSCs Differ in Their In Vitro Behavior and Can Interconvert States Two in vitro assays are widely used to assess stem cell properties and to enumerate in vivo stem cells: adherent colony formation and neurospheres (Pastrana et al., 2011) . With the ability to now prospectively purify qNSCs, we directly tested their in vitro behavior in both assays, as compared to aNSCs. qNSCs and aNSCs were plated as single cells under adherent conditions in the presence of EGF or EGF/basic fibroblast growth factor (bFGF). Whereas aNSCs were enriched in colony formation (47.9% ± 11.9% in EGF and 41.4% ± 1.8% in EGF/ bFGF), in striking contrast, qNSCs only rarely gave rise to colonies (1.2% ± 0.1% in EGF and 0.7% ± 0.2% in EGF/bFGF) ( Figure 5A ) and did so with much slower growth kinetics than aNSCs. Importantly, although rare, the colonies formed by single qNSCs were large and multipotent, giving rise to neurons, oligodendrocytes, and mature astrocytes ( Figures 5B and 5C ).
We next compared the ability of qNSCs and aNSCs to form neurospheres and assessed self-renewal by serial passaging. Again, qNSCs only rarely gave rise to neurospheres (0.85% in EGF, 0.82% in EGF/bFGF) in contrast to aNSCs, which robustly generated neurospheres ( Figure S5B ). Moreover, the proliferation of the qNSC population was delayed by 6 days compared to aNSCs ( Figures 5D and S5A ). However, once activated, qNSCs exhibited similar rates of division to aNSCs. Neurospheres from both populations could be serially passaged more than three times and were multipotent, giving rise to neurons, astrocytes, and oligodendrocytes (Figures S5B and S5E) . Finally, we examined whether more qNSCs were recruited to form neurospheres during in vivo regeneration, at 12 hr postAra-C removal when stem cell astrocytes start to divide (Doetsch et al., 1999a (Doetsch et al., , 1999b Pastrana et al., 2009) . Notably, the efficiency of neurosphere formation of qNSCs purified after Ara-C treatment did not increase ( Figure 5K ). However, as previously shown, total neurosphere formation was almost completely eliminated after Ara-C treatment (Doetsch et al., 2002; Imura et al., 2003; Morshead et al., 2003; Garcia et al., 2004 ; data not shown), confirming that the vast majority of neurospheres arise from actively dividing cells.
Together, these results reveal that aNSCs are highly enriched in colony formation. In contrast, the qNSC population rarely forms colonies and does so more slowly than aNSCs. However, once activated, qNSCs are highly proliferative and multipotent, almost indistinguishable from aNSCs ( Figure S5B ). We therefore assessed whether qNSCs and aNSCs can interconvert in vitro by dissociating and analyzing primary spheres by flow cytometry. Intriguingly, the vast majority of cells in neurospheres derived from qNSCs expressed both EGFR and CD133 ( Figures 5E and 5G Figures  S5C and S5D) . Therefore, qNSCs and aNSCs can interconvert between more quiescent and activated states, with each population giving rise to all other populations in vitro. qNSCs Do Not Express Nestin but Upregulate EGFR and Nestin on Activation Nestin is an intermediate filament protein; its expression is widely considered a hallmark of NSCs, both during development and in the adult (Lendahl et al., 1990; Imayoshi et al., 2011) . Unexpectedly, our microarray analysis (see below) suggested that qNSCs express very low to no levels of Nestin mRNA, in contrast to aNSCs, in which Nestin mRNA is highly expressed. We confirmed this observation by qRT-PCR ( Figure S8E ) as well as by immunostaining of acutely purified cells ( Figure 6A ). Out of 1,582 plated qNSCs, none were Nestin protein positive. Finally, to assess the Nestin status of NSCs in vivo, we electroporated mice with the mP2-mCherry construct and coimmunostained whole mounts with Nestin and EGF-ligand. In vivo, Nestin is highly expressed by ependymal cells (Doetsch et al., 1997 ; 32/34 cells in seven whole mounts).
To investigate whether qNSCs upregulate Nestin protein on activation, we performed a time-course analysis of qNSCs cultured in adherent conditions and immunostained for Nestin, EGFR, and MCM2 ( Figures 6B and 6C ). When first isolated and plated, qNSCs were small and round and did not express Nestin, EGFR, or MCM2 (type 1). As qNSCs became activated in vitro, they underwent morphological and molecular changes, enlarging their nuclei and upregulating all three markers (type 2). They then extended processes (type 3) ( Figures 6B and  6C ) and began to proliferate extensively, closely resembling cultured aNSCs.
To independently confirm the lack of Nestin expression in qNSCs and its upregulation on activation, we used Nestin::Kusabira Orange reporter mice (Kanki et al., 2010; Ishizuka et al., 2011) to FACS-purify CD133 + Nes::
and EGFR-negative) cells ( Figure S7A ). Acutely plated cells all lacked Nestin protein ( Figure S7B ) and, when cultured, only rarely gave rise to neurospheres ( Figures S7C and S7E Figures S7D and S7E ).
Finally, we examined whether Nestin-negative qNSCs contribute to the lineage during regeneration. At present, it is not feasible to directly trace the lineage of qNSCs in vivo due to the lack of specific markers. We therefore administered tamoxifen to adult GFAP::CreERT2;Rosa26 tdTomato mice to induce recombination in GFAP-expressing cells and chased for 10 days after the first injection to allow actively dividing cells to progress down the lineage ( Figure S7F ). We then infused Ara-C for 6 days to eliminate dividing cells (Figure S7F ) and confirmed that all remaining lineage-labeled cells were Nestin negative (0 of 951; Figure S7G ) immediately after termination of treatment. Six days after Ara-C removal, tdTomato + Nestin + cells were present ( Figures S7H and S7I ), as well as tdTomato + DCX + neuroblasts ( Figure S7I ). These data reveal that qNSCs upregulate Nestin, as well as EGFR, during activation and contribute to the lineage during regeneration in vivo.
Gene Expression Analysis of Purified qNSCs and aNSCs Reveals Distinct Molecular Signatures
To gain insight into the biological properties of qNSCs and to define their molecular signatures, we performed microarray analysis on RNA from FACS-purified populations isolated directly from their in vivo niche ( Figure 7A ; Table S1 ). Gene ontology (GO) and gene set enrichment analysis (GSEA) (Subramanian et al., 2005) revealed that qNSCs and aNSCs have distinct molecular features ( Figures 7B-7D ). Confirming the actively dividing state of aNSCs in vivo, their transcriptome was enriched in genes involved in the cell cycle, transcription and translation, and DNA repair (Figures 7C and 7D ; Tables S2 and S3 ). In contrast, qNSCs were enriched in the GO categories of cell communication, response to stimulus, and cell adhesion (Figure 7B ; Table S2 ), underscoring the dynamic regulation of the quiescent state via interaction with the microenvironment. Indeed, the most represented GSEA groups for qNSCs were related to transport, signaling, receptors, cell surface, and extracellular matrix ( Figure 7D ; Table S3 ). Notably, qNSCs and aNSCs exhibited different metabolic profiles; the majority of the differentially enriched GSEA metabolism subsets in qNSCs were related to metabolism of lipids ( Figure S8A ), which are emerging as important signals in NSC regulation (Knobloch et al., 2013) , whereas those in aNSCs were DNA/RNA-related metabolism and proteasome activity ( Figure S8B ). Functional studies have implicated numerous genes in the regulation of adult neurogenesis. Many of these were differentially expressed in qNSCs and aNSCs (Table S5) n = 3. *p < 0.05; ***p < 0.001. ns, not significant. See also Figure S8 and Tables S1, S2 , S3, S4, S5, S6, S7, and S8.
S8D; Table S8 ). Indeed, we found that neurogenic transcription factors such as Dlx1, Dlx2, Sox4, Sox11, and Ascl1, which were proposed to be hallmarks of NSCs (Beckervordersandforth et al., 2010) , were in fact primarily expressed by or restricted to aNSCs (Table S4) . We confirmed enrichment of Dlx2 and Ascl1 in aNSCs by qRT-PCR ( Figures S8F and S8G) , as well as enrichment of Dll1 ( Figure S8H ), which is expressed in aNSCs (Kawaguchi et al., 2013) . In contrast, qNSCs expressed high levels of factors reported to be markers of quiescent stem cells in the adult V-SVZ, such as Vcam1 ( Figure S8I and Table S5 ; Kokovay et al., 2012) , and in other organs, such as Lrig1 ( Figure S8J and Table S1 ; Jensen and Watt, 2006; Jensen et al., 2009; Powell et al., 2012) . We then performed comparative analysis of our gene expression data with transcriptional signatures from quiescent or proliferative hematopoietic, muscle, skin, and intestinal stem cells (Ivanova et al., 2002; Venezia et al., 2004; Forsberg et al., 2010; Pallafacchina et al., 2010; Powell et al., 2012; Blanpain et al., 2004 : Fukada et al., 2007 Cheung and Rando, 2013) . The majority of genes in long-term/quiescent populations were upregulated in our quiescent V-SVZ stem cells, whereas those in the short-term/proliferative stem cell lists from other tissues were upregulated in our activated population (Figures 7E and  7F ; Table S6 ). Together, this suggests that common transcriptional programs for quiescence or activation are shared between stem cell lineages in different tissues.
GPCR Signaling Maintains the Quiescent State
To gain insight into signaling pathways that modulate quiescence in qNSCs, we mined our transcriptome data. G proteincoupled receptor (GPCR) signaling was highly enriched in qNSCs (30% of all GSEA signaling sets; Table S3 ). We selected 25 GPCRs that were more than 10-fold enriched in qNSCs over aNSCs (Table S7) as a basis for a functional screen to assess was quantified ( Figure S8K ). Two compounds, sphingosine-1-phosphate (S1P) and prostaglandin D 2 (PGD 2 ), had a significant effect, with both decreasing the activation of qNSCs by approximately one half ( Figures 7G and S8L ). Both ligands also decreased the number of MCM2 + qNSCs ( Figure 7H ). PGD 2 exerted a more potent effect, completely abolishing MCM2 expression. To determine whether these compounds act specifically on qNSCs or also affect aNSCs, we plated FACS-purified aNSCs in the presence of S1P or PGD 2 and fixed the cells after 24 hr. This shorter time course is necessary as aNSCs divide very rapidly, making it difficult to distinguish individual clones ( Figure S8K ). S1P did not alter the number of aNSC clones ( Figure 7I ) or percentage of MCM2 + cells ( Figure 7J ). As such, S1P selectively targets qNSCs and appears to act at the level of qNSC recruitment ( Figure 7H ). In contrast, PGD 2 had a potent inhibitory effect on the number of clones formed by aNSCs ( Figure 7I ). PGD 2 also reduced the percentage of MCM2 + aNSCs ( Figure 7J ). As such, PGD 2 acts on both qNSCs and aNSCs. Thus, these GPCR ligands actively maintain the adult NSC quiescent state.
DISCUSSION
Here, we prospectively identified and isolated quiescent adult NSCs by defining a combination of markers (CD133, GFAP, and EGFR) that allows the simultaneous purification of quiescent and activated populations of stem cell astrocytes. Together, our analyses of their cell cycle properties, their morphological and anatomical localization, their in vitro and in vivo functional behavior, and their gene expression profiles highlight the distinct functional and molecular properties of qNSCs and aNSCs (Figure 8 ). Our functional analyses reveal important features of quiescent NSCs, which affect the interpretation of commonly used in vitro NSC assays and lineage-tracing strategies.
In the adult mouse brain, CD133 was originally proposed to be exclusively expressed by ependymal cells, with FACS-purified CD133 + cells giving rise to neurospheres in vitro and generating neurons in vivo (Coskun et al., 2008) . However, CD133 is also expressed by a subset of astrocytes, which behave as NSCs (Mirzadeh et al., 2008; Beckervordersandforth et al., 2010) , suggesting that the earlier findings can be attributed to CD133 + astrocytes instead of ependymal cells. Here, we show that CD133 is expressed by both quiescent and activated V-SVZ stem cells. The neurosphere assay is widely used as a readout of in vivo stem cells (reviewed in Pastrana et al., 2011) . Neurospheres were originally proposed to arise from relatively quiescent stem cells in vivo (Morshead et al., 1994) . With the ability to prospectively purify cells at different stages of the stem cell lineage, it is now feasible to directly assess the potential of distinct populations to give rise to neurospheres. Here, we show that qNSCs only very rarely give rise to either neurospheres or adherent colonies and do not increase their neurosphere-forming efficiency during regeneration. In contrast, aNSCs are enriched in neurosphere and adherent colony formation. Together, our current findings and previous reports highlight that the major source of neurosphere-initiating cells are actively dividing in vivo, and include both GFAP + aNSCs and EGFR + GFAP -transit-amplifying cells (Doetsch et al., 2002 , Imura et al., 2003 Morshead et al., 2003; Garcia et al., 2004 , Pastrana et al., 2009 ; data not shown). Thus, the neurosphere assay is a useful tool for assessing the in vitro stem cell potential of proliferative populations but does not allow the identification and enumeration of in vivo quiescent stem cells. This emphasizes the need to develop novel assays, or identify additional niche factors, that allow qNSCs to be expanded in vitro.
Nestin is frequently used both as a marker of NSCs and for their genetic manipulation and lineage tracing in the embryonic (Lendahl et al., 1990; Zimmerman et al., 1994) and adult brain (reviewed in Imayoshi et al., 2011) . Nestin + cells have also been implicated as putative glioblastoma-forming cells , Chen et al., 2012 . Notably, we found that adult V-SVZ qNSCs do not express Nestin but upregulate it on activation in vitro, as well as during regeneration in vivo. These data are consistent with previous observations that Nestin À /CD133 + cells are neurogenic in vivo and give rise to Nestin + neurospheres in vitro (Coskun et al., 2008) . Recently, both Nestin-negative and Nestin-positive radial glia-like stem cells have also been described in the hippocampus (DeCarolis et al., 2013) . As we show here in the V-SVZ, in the SGZ, almost all of the dividing radial glia-like stem cells express Nestin (DeCarolis et al., 2013) . It is interesting that, in embryonic development, Nestin expression is also regulated in a cell-cycle-dependent manner (Sunabori et al., 2008) . Thus, Nestin expression is dynamically regulated in NSCs. Importantly, our study highlights that Nestin immunostaining cannot be used to identify adult qNSCs in vivo. Thus, whether recombination and reporter expression occur in qNSCs needs to be carefully assessed when using Nestin transgenes for in vivo targeting of adult NSCs, V-SVZ lineage tracing, genetic manipulation, or purification. Moreover, interpretation of such assays is further complicated by the high expression of Nestin in ependymal cells, which can lead to nonautonomous effects.
qNSCs are multipotent and self-renewing in vitro. In vivo, qNSCs are long-term neurogenic and exhibit delayed kinetics of neuron formation compared to aNSCs. Interestingly, some aNSC transplants also continue to make neurons 30 days after transplantation. These may arise from a more quiescent subpopulation of aNSCs or from aNSCs that have reverted back to the quiescent state, as occurs in vitro. We also observed oligodendrocyte formation by both transplanted qNSCs and aNSCs (data not shown). In vivo, adult V-SVZ NSCs have regional identity and generate distinct neuronal subtypes, or oligodendrocytes (Merkle et al., 2007; Ventura and Goldman, 2007; Young et al., 2007; Ortega et al., 2013) . At present, we cannot distinguish whether neurons and oligodendrocytes arise from regionally distinct subpopulations of NSCs in the transplanted populations or whether some, or all, NSCs are multipotent in vivo. The extent of in vivo V-SVZ stem cell heterogeneity and population dynamics of qNSCs and aNSCs, as well as their lineage relationships and potential under homeostasis and during regeneration, will require the identification of novel markers allowing the specific targeting of qNSCs and aNSCs. Importantly, our present strategy allows qNSCs to be isolated irrespective of their regional origin. Of note, the GFAP::GFP +
CD133
-population also contains quiescent stem cells. By combining different reporter mice, it is emerging that V-SVZ stem cells are molecularly heterogeneous (Giachino et al., 2014) . The iterative identification of additional markers that allow subpopulations of NSCs to be isolated and targeted in vivo is a key future step. Recent findings suggest that quiescent and activated states are differentially regulated at multiple levels, including cell-cell and extracellular matrix interactions, diffusible signals and distinct transcriptional programs coupling cell cycle regulators, quiescence, self-renewal, and differentiation (Kazanis et al., 2010; Young et al., 2011; Le Belle et al., 2011; Alfonso et al., 2012; Basak et al., 2012; Marqué s-Torrejó n et al., 2013; Kokovay et al., 2012; Porlan et al., 2013; Giachino et al., 2014; Kawaguchi et al., 2013 , Ló pez-Juá rez et al., 2013 Martynoga et al., 2013) . Our transcriptome data of qNSCs and aNSCs isolated directly from their in vivo niche provide a platform to functionally assess the gene regulatory networks active in each state. Interestingly, our GSEA analysis reveals that GPCR signaling is specifically enriched in qNSCs. While GPCRs modulate many different facets of adult neurogenesis (Doze and Perez, 2012) , our findings highlight that they are also key regulators of qNSCs. Strikingly, both functional ligands we identify in our GPCR screen, S1P and PGD 2 , inhibit the activation of qNSCs, suggesting that stem cell quiescence is an actively maintained state. Both S1P and PGD 2 are present in the CSF (Sato et al., 2007; Kondabolu et al., 2011) , which is emerging as a reservoir of factors in the embryo and the adult important for stem cell regulation (Silva-Vargas et al., 2013) . As such, the CSF may be a key niche compartment mediating quiescence in the adult V-SVZ. Interestingly, PGD 2 has been implicated in promoting the quiescent phase of the hair follicle cycle (Garza et al., 2012) , which is consistent with our transcriptome data suggesting that quiescent and activated stem cells in different tissues share common molecular pathways.
As additional mediators of stem cell quiescence and activation are uncovered, it will be important to investigate how clinical drugs targeting these pathways impact NSCs in vivo. For instance, fingolimod, an immunomodulatory drug approved by the Food and Drug Administration for the treatment of multiple sclerosis (Kappos et al., 2006) , acts on S1P receptors. Recent studies have shown that fingolimod also acts on multiple CNS cell types (Groves et al., 2013) , including astrocytes. Our identification of S1P as a regulator of stem cell quiescence suggests that this drug may have an effect on NSCs in the adult brain.
The ability to purify quiescent NSCs from the adult brain opens new vistas into elucidating the biology of stem cell quiescence, enabling studies in their intrinsic and extrinsic molecular regulation and defining their dynamics during development and aging. V-SVZ GFAP + stem cells are also present in humans, where they are largely quiescent (Sanai et al., 2004 (Sanai et al., , 2011 van den Berge et al., 2010) . Understanding the biology of stem cell quiescence and activation will ultimately lead to insight into how NSCs contribute to brain pathology and can be harnessed for brain repair.
EXPERIMENTAL PROCEDURES Animal Use
Experiments were performed in accordance with Columbia University institutional and national guidelines for animal use. All mice used were between 2 and 3 months old.
FACS
The FACS strategy was adapted from Pastrana et al. (2009) . Briefly, the V-SVZ was microdissected from GFAP::GFP mice and dissociated with papain, the single cell suspension was immunostained, and cell populations were purified by FACS as described in the detailed protocol in Supplemental Experimental Procedures.
Immunostaining
Whole mounts were dissected and processed as described elsewhere (Doetsch et al., 1999b; Tavazoie et al., 2008; Mirzadeh et al., 2010) . Briefly, whole mounts were blocked in 10% serum, incubated with primary antibodies for 48 hr at 4 C, revealed with secondary antibodies, and imaged with a Zeiss LSM510 or Leica TCS SP5 II confocal microscope. All immunostainings were performed in triplicate. Immunostaining details for whole mounts and cell cultures are in the Supplemental Experimental Procedures.
In Vitro Assays
For neurosphere assays, FACS-purified cells were collected in neurosphere medium without growth factors and plated at clonal density with EGF (20 ng/ml) or EGF/bFGF (20 ng/ml each). For adherent cultures, purified cells were collected in neurosphere medium and plated on poly-D-lysine and fibronectin-coated 96-well plates as single cells or at clonal density and cultured with EGF or EGF/bFGF. Further details are given in the Supplemental Experimental Procedures.
Ara-C Infusion
A micro-osmotic pump (ALZET, 1007D) filled with 2% Ara-C (Sigma) in 0.9% saline was implanted on to the surface of the brain as described elsewhere (Doetsch et al., 1999b) . After 6 days of Ara-C infusion, mice were sacrificed either immediately or 12 hr after pump removal.
Electroporation
One microliter of a solution containing 5 mg/ml of the mP2-mCherry plasmid in 0.9% saline was electroporated according to Barnabé -Heider et al. (2008) , using the following coordinates: anterior-posterior (AP), 0.0; lateral (L), 0.85; ventral (V), À2.5 mm relative to bregma. The mP2-mCherry plasmid was made by cloning the mouse P2 element of the Prominin1 promoter into the CherryPicker control vector (Clontech), using the XhoI and AgeI digestion sites. See the Supplemental Information for details.
Transplants
Three injections of 0.2 ml delivering 1,000-3,000 cells purified from GFAP::GFP/b-actin-PLAP mice were performed in the SVZ of wild-type recipient mice, using the following coordinates: (1) AP, 0.0; L, 1.4; V, À2.1; (2) AP, 0.5; L, 1.1; V, À2.2; (3) AP, 1.0; L, 1.0; V, À2.5 mm relative to bregma. Recipient mice were sacrificed 1 week or 1 month after transplantation. Transplanted cells were revealed by NBT/BCIP staining.
RNA Isolation and Microarray Hybridization
RNA was purified from FACS-sorted populations with the miRNeasy kit (QIAGEN) from three biological replicates. cDNA was synthesized with the Nugen Pico amplification kit and hybridized to Affymetrix MOE430.2 chips. See Supplemental Information for details of the bioinformatic analysis.
qRT-PCR RNA was purified from FACS-sorted populations with the miRNeasy kit (QIAGEN) and cDNA generated using WT-Ovation Pico System (NuGEN). See Supplemental Information for details on primer sequences.
GPCR Compound Screen
Cells were isolated by FACS and plated on poly-D-lysine-and fibronectincoated 96-well plates in the presence of EGF. To assay the effect on qNSCs, compounds were added 1 day after plating, and cells were fixed and immunostained at day 4. To assay the effect on aNSCs, cells were plated with compounds and fixed and immunostained 1 day later. Further details are in the Supplemental Experimental Procedures.
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